Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-042017
Filing Date
2025-03-19
Accepted
2025-03-19 16:16:17
Documents
97
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sera-20241231.htm   iXBRL 10-K 3392315
2 EX-19.1 sera-ex19_1.htm EX-19.1 139358
3 EX-23.1 sera-ex23_1.htm EX-23.1 9862
4 EX-31.1 sera-ex31_1.htm EX-31.1 14469
5 EX-31.2 sera-ex31_2.htm EX-31.2 14500
6 EX-32.1 sera-ex32_1.htm EX-32.1 9850
7 GRAPHIC img152117643_0.jpg GRAPHIC 314948
8 GRAPHIC img152117643_1.jpg GRAPHIC 350255
9 GRAPHIC img152117643_2.jpg GRAPHIC 272297
10 GRAPHIC img152117643_3.jpg GRAPHIC 291377
  Complete submission text file 0000950170-25-042017.txt   17066072

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sera-20241231.xsd EX-101.SCH 1536563
99 EXTRACTED XBRL INSTANCE DOCUMENT sera-20241231_htm.xml XML 2939531
Mailing Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109
Business Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109 (801) 990-0520
SERA PROGNOSTICS, INC. (Filer) CIK: 0001534969 (see all company filings)

EIN.: 261911522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40606 | Film No.: 25752956
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)